Muscle Oxygen and Hemoglobin Levels After ACL or Hip Surgery

This study is looking at how muscle oxygen (O2) and hemoglobin levels change in people recovering from ACL (anterior cruciate ligament) or hip surgery. We're using a special wearable device called the Moxy Oxygen Sensor Device to measure these levels during physical therapy and workouts. The goal is to see if these measurements can help doctors better understand when it's safe for athletes to return to sports after surgery. We're comparing people who've had surgery with healthy volunteers. You might be able to join if you are between 14 and 30 years old and are having ACL or arthroscopic hip surgery, or if you are a healthy individual in that age range. The study is trying to enroll 226 participants, but its current status is unclear.

Study design
This is an interventional study involving 226 planned participants, including those recovering from ACL or hip surgery and healthy volunteers.
What's involved
If you've had surgery, you'll wear the Moxy sensor during physical therapy at specific times (6 weeks, 12 weeks, 6 months, and 9 months). Healthy volunteers will wear the sensor during a single monitored workout.
Compensation
Not stated in the trial record.
Follow-up
Changes in oxygen saturation and hemoglobin levels will be measured at 6, 9, and 12 months for those who had surgery, and once for healthy individuals.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05488054

Muscle O2 Saturation and Hemoglobin Levels During Rehabilitation From Arthroscopic Surgery

Recruiting
NAAges 14–30InterventionalTreatment
University Hospitals Cleveland Medical Center
~226 participants
Updated 2025-12-24 on ClinicalTrials.gov
What's tested:Physical TherapyMonitored Work-outMoxy Oxygen Sensor Device

At a glance

Recruiting sites
1 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in O2 Saturation levels as measured by Moxy Sensor device
Measured over 6 months, 9 months, 12 months (once for healthy individuals)
+1 more outcome measured
ACL Injury
Hip Injuries

NCT05488054

Where you'd take part

This study runs at 2 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • University Hospitals Cleveland Medial Center

    Cleveland, Ohiostudy coordinator listed

    Recruiting

  • University Hospitals Physical Therapy

    Avon, Ohiostudy coordinator listed

    Not yet recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

  • James Voos, MD · PRINCIPAL_INVESTIGATOR · University Hospitals Cleveland Medical Center
  • Sunita Mengers, MD · STUDY_DIRECTOR · University Hospitals Cleveland Medical Center

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Age range: Patients age 14 to 30 years
Patients with ACL injury requiring surgical correction
Patients undergoing arthroscopic hip surgery
Healthy individuals with no history of ACL, arthroscopic knee or arthroscopic hip surgery

Exclusion

Patients below 14 years or above 30 years
Non-English-speaking subjects
Pregnant individuals
  • Change in O2 Saturation levels as measured by Moxy Sensor device6 months, 9 months, 12 months (once for healthy individuals)
  • Changes in hemoglobin levels as measured by Moxy Sensor device6 months, 9 months, 12 months (once for healthy individuals)